fluoxetine and glyx-13 peptide

fluoxetine has been researched along with glyx-13 peptide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balster, RL; Burgdorf, J; Gross, AL; Kroes, RA; Leander, JD; Moskal, JR; Nicholson, KL; Stanton, PK; Zhang, XL	1

Other Studies

1 other study(ies) available for fluoxetine and glyx-13 peptide

Article	Year
GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013, Volume: 38, Issue:5 Topics: Acoustic Stimulation; Action Potentials; Animals; Antidepressive Agents; Brain; Conditioning, Operant; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Exploratory Behavior; Fluoxetine; Gene Expression Profiling; Ketamine; Long-Term Potentiation; Male; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Reflex, Startle; Swimming	2013

Article

Year

GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013, Volume: 38, Issue:5

Topics: Acoustic Stimulation; Action Potentials; Animals; Antidepressive Agents; Brain; Conditioning, Operant; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Exploratory Behavior; Fluoxetine; Gene Expression Profiling; Ketamine; Long-Term Potentiation; Male; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Reflex, Startle; Swimming

2013